Skip to main content
. 2020 Aug 16;12(8):2307. doi: 10.3390/cancers12082307

Figure 2.

Figure 2

Swimmer plot of time to and duration of response in all patients treated with pembrolizumab. By the time of data cut-off, the second patient from the top was still experiencing a response *. The first patient from the top had stable disease for 24 months.